Assignee
FLUX THERAPEUTICS INC
US·0 granted patents·4 pending applications·0 citations·filing 2021–2021
Top patents by PatentIndex Score
4 records- 0161US2024026330A1Mitochondrial protein targeting engineered deubiquitinases and methods of use thereofFLUX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0261US2024026329A1Nuclear protein targeting deubiquitinases and methods of useFLUX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0358US2024002473A1Membrane protein targeting engineered deubiquitinases and methods of use thereofFLUX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0458US2024025984A1Cytosolic protein targeting deubiquitinases and methods of useFLUX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FLUX THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →